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Introduction
Synaptic adhesion molecules regulate synapse formation, matu-
ration, maintenance, and function (Dalva et al., 2007; Biederer 
and Stagi, 2008; Südhof, 2008; Brose, 2009; Woo et al., 2009; 
Johnson-Venkatesh and Umemori, 2010; Shen and Scheiffele, 
2010; Tallafuss et al., 2010; Williams et al., 2010; Yuzaki, 2010; 
Siddiqui and Craig, 2011). Many known synaptic adhesion 
molecules regulate excitatory synapses, whereas relatively little 
is known about inhibitory synaptic adhesion molecules, which 
include neuroligin 2 and slitrk3 (Südhof, 2008; Takahashi 
et al., 2012).
Neuroligin 2 selectively localizes to inhibitory synapses 
and regulates the formation and function of inhibitory synapses 
(Graf et al., 2004; Varoqueaux et al., 2004; Chih et al., 2005; 
Levinson et al., 2005; Chubykin et al., 2007). Mouse genetic 
studies have confirmed that neuroligin 2 regulates GABAergic 
synapse maturation, inhibitory synaptic transmission, neuronal 
excitability, retinal signal processing, and anxiety-like behav-
iors (Varoqueaux et al., 2006; Chubykin et al., 2007; Blundell 
et al., 2009; Gibson et al., 2009; Hoon et al., 2009; Jedlicka 
et al., 2011; Poulopoulos et al., 2009).
Synaptic adhesion molecules regulate diverse as-pects of synapse formation and maintenance. Many known synaptic adhesion molecules localize 
at excitatory synapses, whereas relatively little is known 
about inhibitory synaptic adhesion molecules. Here we 
report that IgSF9b is a novel, brain-specific, homophilic 
adhesion molecule that is strongly expressed in GABA-
ergic interneurons. IgSF9b was preferentially localized at 
inhibitory synapses in cultured rat hippocampal and cor-
tical interneurons and was required for the development 
of inhibitory synapses onto interneurons. IgSF9b formed 
a subsynaptic domain distinct from the GABAA receptor– 
and gephyrin-containing domain, as indicated by super-
resolution imaging. IgSF9b was linked to neuroligin 2, 
an inhibitory synaptic adhesion molecule coupled to ge-
phyrin, via the multi-PDZ protein S-SCAM. IgSF9b and 
neuroligin 2 could reciprocally cluster each other. These 
results suggest a novel mode of inhibitory synaptic orga-
nization in which two subsynaptic domains, one contain-
ing IgSF9b for synaptic adhesion and the other containing 
gephyrin and GABAA receptors for synaptic transmission, 
are interconnected through S-SCAM and neuroligin 2.
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In the present study, we found that IgSF9b is selectively 
expressed in the brain, strongly expressed in GABAergic inter-
neurons, preferentially localized at inhibitory synapses, and 
required for the development of inhibitory synapses onto inter-
neuronal dendrites. Intriguingly, IgSF9b is localized to a subsyn-
aptic domain distinct from a GABAA receptor/gephyrin-containing 
subsynaptic domain. IgSF9b is linked, via the multi-PDZ 
protein S-SCAM, to neuroligin 2, which is coupled to gephy-
rin. These results suggest a novel mode of inhibitory synaptic 
organization, with detailed molecular mechanisms, where two 
subsynaptic domains with differential functions, i.e., adhe-
sion and transmission, may act synergistically to develop inhib-
itory synapses.
Results
IgSF9b is abundantly expressed in 
GABAergic interneurons
To understand the function of IgSF9b, a structural homologue 
of Dasm1 (Figs. 1 A and S1 A), we first generated two different 
polyclonal antibodies for IgSF9b using two largely independent 
C-terminal regions of IgSF9b as antigens, where they share 
minimal amino acid sequence identities with Dasm1/IgSF9 
(1593 and 1913; Fig. S1, A and B). These two antibodies re-
vealed essentially identical immunostaining patterns in cultured 
hippocampal neurons (Fig. S1 C). In addition, a commercially 
available IgSF9b antibody (HPA010802), raised against another 
independent region (Fig. S1 B), revealed a similar distribution 
pattern (Fig. S1 D). The similar distribution patterns of IgSF9b 
revealed by independent antibodies suggest that the observed 
IgSF9b signals are authentic.
In cultured hippocampal neurons, IgSF9b signals were 
detected in punctate clusters in the cell body and dendrite re-
gions of GABAergic interneurons that are positive for the GABA 
synthetic enzyme glutamic acid decarboxylase GAD67. The 
majority of GABAergic neurons (80%) exhibited punctate 
IgSF9b immunofluorescence (n = 15). In contrast, relatively 
weak signals were detected in some but not all GAD67-negative 
pyramidal neurons (Fig. 1 B). These results indicate that IgSF9b 
is more abundant in GABAergic interneurons than in pyra-
midal neurons.
IgSF9b is mainly present at  
inhibitory synapses
IgSF9b clusters colocalized with the vesicular GABA trans-
porter (VGAT; an inhibitory presynaptic protein) in pyramidal 
neurons (Fig. 1 C) and in interneurons (Fig. 1 D). IgSF9b also 
colocalized with gephyrin, an inhibitory postsynaptic protein, 
and the 1 subunit of GABAA receptors in interneurons (Fig. 1, 
E and F). In contrast, IgSF9b minimally colocalized with the 
vesicular glutamate transporter vGlut1 and Shank (excitatory 
pre- and postsynaptic proteins, respectively) in interneurons 
(Fig. 1 G). In quantitative analysis, 78% of IgSF9b puncta 
colocalized with GAD67 (n = 20).
In cultured cortical neurons, IgSF9b displayed distribution 
patterns similar to those observed in hippocampal neurons, being 
more abundant in GAD65-positive GABAergic interneurons 
Neuroligin 2 interacts extracellularly with presynaptic 
neurexins and triggers inhibitory presynaptic differentiation in 
contacting axons (Graf et al., 2004; Chih et al., 2005; Levinson 
et al., 2005). The cytoplasmic region of neuroligin 2 contains 
two motifs involved in protein–protein interactions. The one lo-
cated in the middle of the cytoplasmic region directly interacts 
with gephyrin (Poulopoulos et al., 2009), a major inhibitory 
postsynaptic scaffold (Fritschy et al., 2008; Fritschy et al., 
2012). This interaction is thought to lead to a close apposition 
of neuroligin 2 with various gephyrin-associated proteins, in-
cluding GABAA receptors and glycine receptors (Fritschy et al., 
2008, 2012). Notably, neuroligin 2, but not other neuroligins, 
selectively activates collybistin, a RhoGEF for Cdc42 that binds 
both gephyrin and the plasma membrane and, thus, leads to the 
stable tethering of gephyrin to the inhibitory synaptic mem-
brane (Poulopoulos et al., 2009).
The C terminus of neuroligin 2 contains a PDZ-binding 
motif that interacts with PSD-95 (Irie et al., 1997) and S-SCAM 
(also known as MAGI-2; Sumita et al., 2007), two postsynap-
tic scaffolding proteins equipped with multiple domains for 
protein–protein interactions including PDZ and GK domains 
(Hirao et al., 1998; Sheng and Kim, 2011). The functional sig-
nificance of the interaction between neuroligin 2 and PSD-95 
remains unclear because these two proteins mainly localize at 
inhibitory and excitatory synapses, respectively (Sumita et al., 
2007; Sheng and Kim, 2011).
S-SCAM, however, distributes to both excitatory and 
inhibitory synapses, with 35% of clusters being detected at 
inhibitory synapses, which is dissimilar to PSD-95 (Sumita 
et al., 2007). This suggests the possibility that S-SCAM, to-
gether with its binding partner neuroligin 2, contributes to the 
organization of inhibitory synapses. Moreover, highlighting the 
clinical importance of S-SCAM, chromosomal mutations in 
the human S-SCAM/MAGI-2 gene have been associated with 
infantile spasm (also known as West syndrome), an epileptic 
disorder characterized by seizure, distinct EEG (termed hyp-
sarrhythmia), and intellectual disability (or mental retardation; 
Marshall et al., 2008).
Dasm1 (also known as IgSF9; Doudney et al., 2002) 
is an Ig superfamily (IgSF) adhesion molecule reported to 
regulate dendritic arborization and excitatory synaptic matu-
ration in hippocampal neurons by knockdown and dominant-
negative approaches (Shi et al., 2004a,b), although a more 
recent study using mice deficient of Dasm1/IgSF9 showed 
that dendritic arborization in hippocampal neurons from these 
animals is normal (Mishra et al., 2008). A Drosophila homo-
logue of Dasm1 known as Turtle regulates dendritic branch-
ing and self-avoidance as well as axonal path finding and 
self-avoidance (Doudney et al., 2002; Al-Anzi and Wyman, 
2009; Ferguson et al., 2009; Long et al., 2009). Dasm1 in 
mammals has a close relative termed IgSF9b, which shares 
a similar domain structure with Dasm1; five Ig domains, two 
fibronectin III (FNIII) domains, one transmembrane domain, 
and a C-terminal PDZ-binding motif. Importantly, IgSF9b 
has recently been associated with major depressive disorder 
(Shyn et al., 2011), but the physiological function of IgSF9b 
remains unexplored.
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results. Levels of IgSF9b proteins increased gradually during 
the first 3 wk of postnatal rat brain development (Fig. 2 D). 
Similar increases were also observed in dissociated hippocam-
pal neurons (Fig. S2, C–E). IgSF9b was more abundant in syn-
aptic fractions, including crude synaptosomes (P2) and synaptic 
plasma membranes (LP1), relative to other subcellular frac-
tions. A similar synaptic abundance could also be observed for 
known inhibitory synaptic proteins including neuroligin 2, gephy-
rin, and GABAA receptor subunits (1 and 2; Fig. 2 E).
Within crude synaptosomes, IgSF9b was highly enriched 
in postsynaptic density (PSD) fractions, being detected in PSD 
III, the most detergent-resistant PSD fraction (Fig. 2 F). This 
extent of PSD enrichment is comparable to that of PSD-95, an 
excitatory postsynaptic scaffolding protein tightly associated 
with the PSD. Notably, the 2 subunit of GABAA receptors 
was also highly detected in PSD III, whereas neuroligin 2 and 
the 1 subunit of GABAA receptors were enriched up to PSD II. 
These results suggest that IgSF9b, together with the 2 subunit of 
GABAA receptors, is tightly associated with inhibitory synapses.
Because IgSF9b is a novel membrane protein, we examined 
glycosylation patterns of IgSF9b. Neuraminidase significantly re-
duced the size of IgSF9b, whereas O-glycosidase combined with 
neuraminidase did not further reduce the size of IgSF9b (Fig. 2 G), 
indicating that IgSF9b is mainly modified by sialylation, but not 
by O-glycosylation. PNGase F slightly reduced the size of IgSF9b, 
which indicates that IgSF9b is moderately N-glycosylated.
(Fig. 1 H), and being mainly present at inhibitory synapses 
(Fig. 1, I and J). IgSF9b colocalized with gephyrin but not with 
PSD-95 in interneurons (Fig. 1, K and L). These results indicate 
that IgSF9b mainly localizes to inhibitory synapses. Whereas 
IgSF9b signals were strong in dissociated neurons, IgSF9b 
immunofluorescence in rat brain slices could not be easily 
detected, perhaps because of antigen masking by tight associa-
tion of IgSF9b with synapses (see the paragraph below describ-
ing Fig. 2 F).
Expression patterns of IgSF9b
We first examined distribution patterns of IgSF9b mRNAs in 
the rat brain by in situ hybridization. IgSF9b mRNAs were de-
tected in various rat brain regions including cortex, hippocam-
pus, thalamus, olfactory bulb, and cerebellum (Fig. 2 A). In 
addition to the longest splice variant of IgSF9b, two shorter 
variants may be expressed based on the database (Fig. S2 A). 
However, in situ probes directed to the three different mRNA 
regions revealed similar expression patterns in the mouse brain 
(Fig. S2 B), which suggests that the two shorter variants, if ex-
pressed, are unlikely to be expressed in different cell types.
In Western blot analysis, IgSF9b proteins (190 kD) were 
mainly detected in the brain but not in other tissues (Fig. 2 B). 
IgSF9b proteins were detected in brain regions including cortex, 
hippocampus, cerebellum, and striatum, as revealed by immuno-
blot analysis (Fig. 2 C), similar to the in situ hybridization 
Figure 1. IgSF9b is abundant in GABAergic interneurons and mainly present at inhibitory synapses. (A) Domain structure of IgSF9b. SP, signal peptide; 
Ig, immunoglobulin domain; FNIII, fibronectin type III domain; TM, transmembrane domain; PB, PDZ domain-binding motif. (B) IgSF9b signals are more 
abundant in interneurons than in pyramidal neurons. Cultured hippocampal neurons (DIV 28, a stage after IgSF9b reaches a plateau of its expression) were 
labeled by triple immunofluorescence staining for IgSF9b, GAD67, and MAP2. Yellow and red asterisks indicate cell bodies of GAD67-positive interneu-
rons and GAD67-negative pyramidal neurons, respectively. (C and D) IgSF9b colocalizes with VGAT (an inhibitory presynaptic protein) both in pyramidal 
neurons (C) and in interneurons (D). The bottom images are enlarged views of the boxed regions. (E–G) IgSF9b colocalizes with gephyrin (E) and the 1 
subunit of GABAA receptors (F) at VGAT- or GAD65 (an inhibitory presynaptic protein)-positive inhibitory synapses, but not with vGlut1 (an excitatory pre-
synaptic protein)- or Shank (an excitatory postsynaptic protein)-positive excitatory synapses (G) in interneurons. (H–J) In cultured cortical neurons at DIV 28, 
IgSF9b is more abundantly expressed in GAD65-positive interneurons than in GAD65-negative pyramidal neurons, and colocalizes with GAD65-positive 
inhibitory synapses (I and J). (K and L) IgSF9b colocalizes with gephyrin and GAD65 but not with PSD-95 in dendrites of cortical interneurons. Bars: (B) 20 µm; 
(C and D, top rows) 20 µm; (C and D, bottom rows) 5 µm; (E–G) 10 µm; (H) 20 µm; (I–L) 5 µm.
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dendrites. In the coculture (or mixed culture) assay, an assay 
commonly used to test the capabilities of adhesion molecules to 
trigger synapse formation (Scheiffele et al., 2000; Biederer and 
Scheiffele, 2007), IgSF9b-expressing HEK293T cells did not 
induce clustering of the presynaptic protein synapsin I, VGAT, 
or vGlut1 in contacting axons of cocultured hippocampal neu-
rons (Fig. 3, D and E; and Fig. S3, C–F). Similarly, IgSF9b did 
not induce clustering of postsynaptic proteins (gephyrin and 
PSD-95) in contacting dendrites of GABAergic interneurons 
and pyramidal neurons (Fig. 3, F–I; and Fig. S3, G and H). 
These results suggest that IgSF9b lacks the activity to induce 
synaptic protein clustering in contacting axons and dendrites.
Postsynaptic IgSF9b knockdown reduces 
the number of VGAT-positive gephyrin 
clusters in interneurons
Although IgSF9b alone is not sufficient to trigger synapse for-
mation, IgSF9b may still regulate inhibitory synaptic functions. 
To this end, we generated an IgSF9b shRNA knockdown con-
struct (sh-IgSF9b) coexpressing EGFP, along with a mutant 
sh-IgSF9b construct that lacks knockdown activity (sh-IgSF9b*) 
as a control. When expressed in HEK293T cells and cultured 
hippocampal neurons (day in vitro [DIV] 15–20), sh-IgSF9b 
substantially reduced IgSF9b expression by 70% in cultured 
neurons (Fig. S4, A–D). We expressed sh-IgSF9b or control 
IgSF9b mediates homophilic adhesion
IgSF9b contains adhesion domains (Ig and FNIII) in the extra-
cellular region, and turtle, a Drosophila homologue of IgSF9b 
and Dasm1/IgSF9, mediates homophilic adhesion (Ferguson 
et al., 2009). To test whether IgSF9b mediates homophilic adhe-
sion, we incubated HEK293T cells expressing IgSF9b with re-
combinant, soluble IgSF9b protein (the ectodomain of IgSF9b 
fused to human Fc; IgSF9b-Ecto-Fc). IgSF9b-Ecto-Fc bound to 
IgSF9b on HEK293T cells but not to other adhesion molecules, 
including Dasm1/IgSF9 (Fig. 3 A), which suggests that IgSF9b 
mediates homophilic adhesion.
In addition, IgSF9b expressed in HEK293T cells accumu-
lated at sites of cell–cell contacts (Fig. 3 B). Moreover, IgSF9b 
on HEK293T cells induced accumulation of IgSF9b on contact-
ing neurites of cocultured neurons, whereas control HEK293T 
cells expressing EGFP alone did not (Fig. 3 C). Similar results 
were obtained in GABAergic interneurons and pyramidal neu-
rons (Fig. S3, A and B). These results suggest that IgSF9b me-
diates homophilic cell adhesion.
IgSF9b is not sufficient to induce  
synapse formation
Given that IgSF9b is a homophilic adhesion molecule enriched 
at inhibitory synapses, IgSF9b might function as a synaptic or-
ganizer that induces protein clustering in contacting axons and 
Figure 2. Expression patterns of IgSF9b. (A) Distribution of IgSF9b mRNA in rat brain sections revealed by in situ hybridization. OB, olfactory bulb; Ctx, 
cortex; Hc, hippocampus; Cb, cerebellum. (B) IgSF9b protein is mainly expressed in the rat brain, as revealed by immunoblot analysis. Untransfected 
(Untrans) and IgSF9b-transfected (IgSF9b) HEK cell lysates were used as controls. Sk. muscle, skeletal muscle. (C) Widespread distribution of IgSF9b pro-
teins in rat brain regions. Str, striatum; R, the rest of the brain regions. (D) IgSF9b protein levels gradually increase during postnatal rat brain development 
and reach a peak at 3 wk. Whole brain homogenates were used. E, embryonic day; P, postnatal day. (E) IgSF9b is more abundant in synaptic rat brain 
fractions including crude synaptosomes (P2) and synaptic membranes (LP1), relative to other subcellular fractions. Equal amounts of proteins (10 µg) were 
loaded into each lane. H, homogenates; S2, supernatant after P2 precipitation; S3, cytosol; P3, light membranes; LS2, synaptosomal cytosol; LP2, synaptic 
vesicle-enriched fraction. (F) Enrichment of IgSF9b in PSD fractions within crude synaptosomes. PSD fractions were prepared by extraction of synaptosomes 
with Triton X-100 once (PSD I), twice (PSD II), or with Triton X-100 and sarcosyl (PSD III). The amounts of proteins loaded are indicated. (G) IgSF9b is 
modified strongly by sialylation, moderately by N-glycosylation, and minimally by O-glycosylation. The crude synaptosomal (P2) fraction of adult rat brains 
was treated with neuraminidase (for sialylation), neuraminidase + O-glycosidase (for sialylation + O-glycosylation), and PNGase F (for N-glycosylation). 
SynCAM and PSD-95 were used as positive and negative controls, respectively.  o
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by VGAT-positive gephyrin clusters, compared with empty 
shRNA vector (sh-vec; negative control; Fig. 4, A and B). In con-
trast, sh-IgSF9b* had no effect on inhibitory synapse number 
in interneurons. IgSF9b knockdown had no effect on excitatory 
synapse number (vGlut1-positive PSD-95 clusters) in interneu-
rons (Fig. 4, C and D). In pyramidal neurons, where weaker 
IgSF9b expression is observed, sh-IgSF9b caused a tendency 
constructs in a small fraction of neurons in culture and assessed 
synapses made onto the somatodendritic domain of these neu-
rons. In this system, the presynaptic inputs arise mainly from 
surrounding untransfected axons, thus knockdown will reveal 
roles of postsynaptic IgSF9b.
sh-IgSF9b expressed in interneurons caused a small but 
significant decrease in the number of inhibitory synapses, defined 
Figure 3. IgSF9b mediates homophilic adhesion but is not sufficient to induce synapse formation. (A) Homophilic adhesion by IgSF9b. HEK293T express-
ing IgSF9b-pDis (ectodomain of IgSF9b in pDisplay vector), or other synaptic adhesion molecules, were incubated with IgSF9b-Ecto-Fc, followed by stain-
ing for Fc and the expressed adhesion molecules. (B) IgSF9b accumulates at sites of cell–cell contacts. HEK293T cells were transfected with C-terminally 
Flag-tagged IgSF9b that lacks the cytosolic region (IgSF9b-Flag), and stained for Flag. (C) IgSF9b-expressing HEK293T cells induce clustering of IgSF9b in 
contacting neurites of cocultured neurons. HEK293T cells expressing IgSF9b-Flag were cocultured with hippocampal neurons transfected with IgSF9b-pDis 
(detected with anti-HA). (D–I) IgSF9b-expressing HEK293T cells do not induce clustering of synapsin I (D), gephyrin (F), or PSD-95 (H) in contacting axons 
or dendrites. HEK293T cells transfected with IgSF9b-pDis, or EGFP alone (negative control), were cocultured with hippocampal neurons (DIV 9–12) and 
stained for the indicated synaptic proteins. (E, G, and I) Quantification of integrated intensities of the synaptic proteins on HEK293T cells normalized to the 
cell area. au, arbitrary units. Error bars indicate mean ± SEM. n = 15 (EGFP) and 16 (IgSF9b) for synapsin I, 14 and 16 for gephyrin, and 15 and 18 for 
PSD-95. A Student’s t test was used. Bars: (A and B) 10 µm; (C) 20 µm; (D, F, and H) 20 µm.
Figure 4. IgSF9b knockdown reduces the number of VGAT-positive gephyrin clusters and the frequency of inhibitory synaptic transmission in interneurons. 
(A) IgSF9b knockdown reduces the number of inhibitory synapses (VGAT-positive gephyrin) in interneurons. Cultured hippocampal neurons expressing 
sh-vec, sh-IgSF9b, or sh-IgSF9b* (DIV 15–20) were triply stained for EGFP, gephyrin, and VGAT. Bar, 10 µm. (B) Quantification of the results from A. 
n = 22; *, P < 0.05, ANOVA and Tukey’s multiple comparison test. (C) IgSF9b knockdown has no effect on the number of excitatory synapses (vGlut1-
positive PSD-95) in interneurons. Bar, 10 µm. (D) Quantification of the results from C. n = 19, ANOVA and Tukey’s multiple comparison test. (E–G) IgSF9b 
knockdown reduces the frequency (F) but not amplitude (G) of mIPSCs in interneurons. Sample traces of mIPSCs are shown in E. n = 22 for sh-vec and 20 
for sh-IgSF9b; *, P < 0.05; Student’s t test. (H–J) IgSF9b knockdown has no effect on the frequency (I) or amplitude (J) of mEPSCs in interneurons. n = 22 
for sh-vec and 20 for sh-IgSF9b, Student’s t test. Error bars indicate mean ± SEM.
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(Fig. 4, E and G). Contrary to mIPSCs, sh-IgSF9b had no effect 
on miniature excitatory postsynaptic currents (mEPSCs) in both 
frequency and amplitude (Fig. 4, H–J). Therefore, postsynaptic 
IgSF9b is required for normal frequency of inhibitory transmis-
sion in interneurons, which is consistent with its role in control-
ling inhibitory synapse number.
IgSF9b and gephyrin/GABAA receptors 
display distinct subsynaptic distributions
While searching for mechanisms underlying IgSF9b-dependent 
inhibitory synapse development, we turned to the observation 
that IgSF9b and gephyrin often display close but partially non-
overlapping localization at GAD65-positive inhibitory synapses 
in cultured hippocampal neurons (Fig. 5 A). We thus tested 
more systematically various combinations of double staining 
to reduce inhibitory synapse number, although it did not reach 
statistical significance (Fig. S4, E–H). These results suggest 
that postsynaptic IgSF9b is important for the development of 
inhibitory synapses in interneurons, which is consistent with the 
finding that IgSF9b is abundantly expressed in interneurons and 
is mainly present at inhibitory synapses.
Postsynaptic IgSF9b knockdown  
reduces inhibitory synaptic transmission  
in interneurons
We next evaluated whether IgSF9b knockdown affects inhibi-
tory synaptic transmission. IgSF9b knockdown reduced the fre-
quency of miniature inhibitory postsynaptic currents (mIPSCs) 
in interneurons, whereas sh-vec had no effect (Fig. 4, E and F). 
The amplitude of mIPSCs, however, was unaffected by sh-IgSF9b 
Figure 5. Gephyrin colocalizes with neuroligin 2 and the 2 subunit of GABAA receptors, whereas IgSF9b displays close but minimally overlapping 
localization with gephyrin or the 2 subunit of GABAA receptors. (A) In normal-resolution immunofluorescence imaging, IgSF9b and gephyrin show closely 
associated but distinct distribution patterns at GAD65-positive inhibitory synapses. Cultured hippocampal neurons (DIV 21) were triply stained for IgSF9b, 
gephyrin, and GAD65. (B and C) Cultured hippocampal neurons (DIV 21) were visualized by the combinations of double staining indicated and normal 
(non-STORM) light microscopy. Bars: (A, left) 20 µm; (A, right) 2 µm; (B and C) 1 µm.
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Because gephyrin and the 2 subunit of GABAA receptors 
are considered to be core components of the inhibitory synapse 
(Fritschy et al., 2008; Luscher et al., 2011; Fritschy et al., 2012), 
these results suggest that IgSF9b forms an inhibitory subsynap-
tic domain that is intimately associated with, but distinct from, 
the core complex containing GABAA receptors and gephyrin.
IgSF9b interacts with S-SCAM at 
inhibitory synapses
The close apposition between IgSF9b- and GABAA receptor/
gephyrin-containing inhibitory subsynaptic domains suggests 
that there might be a molecular mechanism linking the two 
domains. To this end, we searched for proteins that interact 
with IgSF9b.
In a yeast two-hybrid screen with the IgSF9b C terminus 
(last 75 aa residues), which contains a PDZ domain–binding 
motif, we identified MAGI-1 (human), a member of the S-SCAM/
MAGI family (Hirao et al., 1998), as a novel binding partner of 
IgSF9b. Because MAGI-1 has been reported to be absent from 
inhibitory synapses (Sumita et al., 2007), we focused on S-SCAM 
of inhibitory synaptic proteins. Gephyrin, the 2 subunit of 
GABAA receptors, and neuroligin 2 in pairwise combinations 
showed substantial overlap (Fig. 5 B). In contrast, IgSF9b 
often minimally overlapped or formed clusters adjacent but 
nonoverlapping with gephyrin or the 2 subunit of GABAA 
receptors (Fig. 5 C).
To further explore this at a higher resolution, we used 
super-resolution immunofluorescence imaging using the two-
color stochastic optical reconstruction microscopy (STORM) 
method, which provides a resolution up to 10 times higher than 
that of regular immunofluorescence imaging and has been suc-
cessful in revealing subsynaptic localization of synaptic pro-
teins (Bates et al., 2007; Dani et al., 2010). This approach 
revealed that IgSF9b and gephyrin localize to distinct subsyn-
aptic domains at inhibitory synapses in cultured hippocampal 
neurons (Fig. 6 A). Similarly, IgSF9b and the 2 subunit of 
GABAA receptors showed distinct distribution patterns at inhib-
itory synapses (Fig. 6 B). In contrast, gephyrin and the 2 sub-
unit of GABAA receptors showed substantially overlapping 
distribution patterns (Fig. 6 C).
Figure 6. IgSF9b and gephyrin/GABAA receptors localize to distinct subsynaptic domains at inhibitory synapses. (A and B) In super-resolution imaging, 
IgSF9b and gephyrin, or IgSF9b and the 2 subunit of GABAA receptors, show closely associated but minimally overlapping distribution patterns. Cultured 
hippocampal neurons at DIV 19–20 were used. (C) In super-resolution imaging, gephyrin and the 2 subunit of GABAA receptors show substantially over-
lapping distribution patterns. Cultured hippocampal neurons at DIV 19–20 were used. Bars: (A and B, left) 1,000 nm; (A and B, insets) 100 nm; (C, left) 
2,000 nm; (C, inset) 250 nm.
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with its inhibitory synaptic localization. In addition, MAGI pro-
teins formed a complex with neuroligin 2 (Fig. 7 B), which is 
consistent with the previously reported interaction between 
S-SCAM and neuroligin 2 (Sumita et al., 2007).
In cultured hippocampal neurons, IgSF9b colocalized with 
MAGI proteins on dendrites (Fig. 7 C). Furthermore, specifi-
cally in GABAergic interneurons, we found that MAGI proteins 
clustered at GAD67-positive inhibitory synapses, using both 
an antibody generated in this study (2015; Fig. S5, A and B), 
and an independent antibody (42574; Fig. S5, C and D). In ad-
dition, some MAGI proteins colocalized with vGlut1 clusters 
in interneurons (Fig. S5 E). To specifically test the localization 
(MAGI-2), which is highly similar to MAGI-1 and known to be 
present at inhibitory synapses (Sumita et al., 2007). In an in vitro 
binding assay, IgSF9b formed a complex with S-SCAM but 
not with PSD-95 or gephyrin in HEK293T cells (Fig. 7 A). To 
assess endogenous association of IgSF9b with S-SCAM, we 
were limited by cross-reactivity of our anti–S-SCAM antibodies 
with MAGI-1 (Fig. S5, A and B), and thus assessed association 
of IgSF9b with S-SCAM using these pan-MAGI antibodies. In 
the brain, IgSF9b coprecipitated with MAGI proteins but not 
with other postsynaptic scaffolds including gephyrin, PSD-95, 
and Shank (Fig. 7 B). Notably, IgSF9b formed a weak complex 
with neuroligin 2 but not with neuroligin 1, which is consistent 
Figure 7. IgSF9b interacts with S-SCAM at inhibitory synapses. (A) IgSF9b forms a complex with S-SCAM, but not with PSD-95 or gephyrin, in heterolo-
gous cells. HEK293T cells transfected with IgSF9b (untagged) + tagged S-SCAM, PSD-95, or gephyrin were immunoprecipitated and immunoblotted with 
the indicated antibodies. The bottom panels indicate immunoprecipitation experiments performed in a reverse orientation. IP, immunoprecipitation; IB, 
immunoblot. (B) IgSF9b forms a complex with S-SCAM and neuroligin 2, but not with PSD-95, Shank, or neuroligin 1, in the brain. In addition, MAGI pro-
teins form a complex with neuroligin 2. Lysates of the crude synaptosomal fraction from adult rat brains (6 wk) were immunoprecipitated with IgSF9b (left) 
or pan-MAGI (right) antibodies and immunoblotted. (C) IgSF9b colocalizes with MAGI proteins in cultured neurons. Cultured hippocampal neurons at DIV 
16 were stained for endogenous IgSF9b, S-SCAM, and MAP2. Arrowheads indicate sites of colocalization. Bar, 10 µm. (D) Domain structure of S-SCAM. 
Neuroligin 2– or IgSF9b-binding regions are indicated. PDZ, PSD-95/Dlg/ZO-1 domain; GK, guanylate kinase-like domain. (E and F) PDZ2-5 of S-SCAM 
is sufficient for IgSF9b binding, whereas WW-PDZ1 mediates neuroligin 2 binding. EGFP–S-SCAM (full-length and deletion variants) cotransfected with 
IgSF9b or with HA-Neuroligin 2 in HEK293T cells were immunoprecipitated and immunoblotted. The absence of EGFP–S-SCAM band (200 kD) in lane 2 
is due to low expression levels of EGFP–S-SCAM and a limited film exposure. (G) PDZ4-5 domains of S-SCAM are sufficient for IgSF9b binding.
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(Fig. 9 A). In cultured hippocampal neurons treated with preclus-
tered neurexin 1, primary clustering of endogenous neuroligin 
2 induced coclustering of MAGI proteins and IgSF9b at subcel-
lular sites lacking VGAT (Fig. 9, B and C).
Conversely, in cultured neurons expressing N-terminally 
EGFP-tagged IgSF9b, direct aggregation of IgSF9b by GFP 
antibody–coated beads induced coclustering of endogenous 
neuroligin 2 at sites that lack synapsin I (Fig. 9, D and E). These 
results suggest that the formation of the ternary complex con-
taining IgSF9b, S-SCAM, and neuroligin 2 can be driven bidi-
rectionally, initiating from neuroligin 2 or IgSF9b.
Neuroligin 2 does not affect the general 
stability or synaptic localization of IgSF9b
IgSF9b and neuroligin 2, which can bidirectionally drive pro-
tein clustering, may also regulate the synaptic localization or 
general stability of each other. However, neuroligin 2 deletion 
in mice, which has been reported previously (Varoqueaux et al., 
2006), had no effect on overall levels of IgSF9b, as determined 
by immunoblot analysis of whole-brain lysates (Fig. 9, F and G). 
In addition, neuroligin 2 deficiency had no effect on synaptic 
levels of IgSF9b, as determined by immunoblot analysis of syn-
aptic brain fractions including synaptosomal membranes and 
PSD fractions where IgSF9b is highly enriched (Fig. 9, F and G). 
These results suggest that neuroligin 2 has minimal influences 
on overall stability or synaptic localization of IgSF9b.
Gephyrin can be clustered by neuroligin  
2 but not by IgSF9b
Because IgSF9b can drive coclustering of neuroligin 2 (Fig. 9, 
D and E), we tested whether IgSF9b can also drive cocluster-
ing of gephyrin, an inhibitory postsynaptic scaffold that di-
rectly interacts with neuroligin 2 (Poulopoulos et al., 2009) 
and diverse inhibitory postsynaptic proteins including GABAA 
and glycine receptors and signaling, cytoskeletal, and traffick-
ing proteins (Fritschy et al., 2008). However, bead aggrega-
tion of IgSF9b in cultured neurons did not induce coclustering 
of gephyrin (Fig. 10, A and B), despite the fact that it could 
cocluster neuroligin 2 (Fig. 10 C). In contrast, bead aggrega-
tion of neuroligin 2 could induce coclustering of gephyrin at 
VGAT-negative sites, whereas CD4 (a negative control) could 
not (Fig. 10, A and B). Similarly, neuroligin 2 aggregation by pre-
clustered neurexin 1 induced gephyrin coclustering (Fig. 9 B). 
These results suggest that gephyrin can be clustered by neuro-
ligin 2 but not by IgSF9b.
Discussion
IgSF9b, a novel inhibitory synaptic 
adhesion molecule
In the present study, we have identified IgSF9b as a novel in-
hibitory synaptic adhesion molecule.
IgSF9b differs from Dasm1/IgSF9 in several aspects. Dasm1 
is mainly localized at and regulates excitatory synapses (Shi et al., 
2004a,b), whereas IgSF9b mainly regulates inhibitory synapses. 
In addition, Dasm1 does not associate with IgSF9b (Fig. 3 A), 
despite the fact that they show substantial amino acid identity in 
of S-SCAM independent of MAGI-1, we expressed tagged 
S-SCAM at a low level in cultured neurons. Exogenously ex-
pressed EGFP-tagged S-SCAM partially localized at VGAT-
positive inhibitory synapses in both interneurons and pyramidal 
neurons (Fig. S5, F and G). This colocalization is in line with 
the previous finding that 35% of S-SCAM clusters are detected 
at inhibitory synapses in cultured hippocampal neurons (Sumita 
et al., 2007). Collectively, these data suggest that S-SCAM 
is present at both excitatory and inhibitory synapses in inter-
neurons, which is consistent with the molecular and biochemi-
cal associations
We next mapped minimal IgSF9b-binding domains in 
S-SCAM. Among the three deletion variants of S-SCAM tested 
(PDZ0–GK, WW–PDZ1, and PDZ2–5), PDZ2–5 was suffi-
cient for IgSF9b binding (Fig. 7, D–F). WW–PDZ1 interacted 
with neuroligin 2, as previously reported (Sumita et al., 2007). 
Experiments with additional deletion variants of S-SCAM re-
vealed that PDZ4–5 of S-SCAM is sufficient for IgSF9b bind-
ing (Fig. 7 G).
S-SCAM bridges IgSF9b and neuroligin 2
Because two distinct regions of S-SCAM bind IgSF9b and neu-
roligin 2 (Figs. 7 D and 8 A), we tested whether the three pro-
teins can form a ternary complex. In heterologous cells, IgSF9b 
coprecipitated with neuroligin 2 only in the presence of S-SCAM 
(Fig. 8 B), which is consistent with the coprecipitation of IgSF9b 
with neuroligin 2 and MAGI proteins in the brain (Fig. 7 B). In 
addition, IgSF9b colocalized with both MAGI proteins and neuro-
ligin 2, but not with PSD-95, in cultured interneurons (Fig. 8 C). 
These results suggest that IgSF9b forms a ternary complex with 
S-SCAM and neuroligin 2 at inhibitory synapses.
To see if S-SCAM is critically involved in linking IgSF9b 
and neuroligin 2 clusters in neurons, we tested whether S-SCAM 
knockdown decreases the colocalization between IgSF9b and 
neuroligin 2. We found that S-SCAM knockdown (sh-S-SCAM, 
DIV 15–20) in cultured interneurons suppressed the colocaliza-
tion between IgSF9b and neuroligin 2, whereas it had no effect on 
the number of single IgSF9b or neuroligin 2 clusters (Fig. 8, D–G). 
A mutant knockdown construct that lacks the knockdown activity 
(sh-S-SCAM*) had no effect on the colocalization between 
IgSF9b and neuroligin 2. In addition, S-SCAM knockdown de-
creased the number of VGAT-positive gephyrin clusters (Fig. 8, 
H and I). These results suggest that S-SCAM is required for the 
close association between IgSF9b- and neuroligin 2–containing 
subsynaptic domains in interneurons, and that S-SCAM is re-
quired for the development or maintenance of inhibitory synap-
tic structures containing gephyrin and VGAT.
IgSF9b and neuroligin 2 bidirectionally 
drive protein clustering
The formation of the ternary complex between IgSF9b, S-SCAM, 
and neuroligin 2 may be driven unidirectionally by IgSF9b or 
neuroligin 2, or bidirectionally. To test this idea, HEK293T cells 
triply expressing IgSF9b, S-SCAM, and neuroligin 2 were incu-
bated with preclustered neurexin 1 ectodomain to induce neu-
roligin 2 aggregation. This aggregation induced coclustering of 
IgSF9b only in the presence of S-SCAM in heterologous cells 
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2002; Varoqueaux et al., 2004; Fritschy et al., 2012). In culture, 
IgSF9b contributes mainly to inhibitory synapses onto GABAergic 
interneurons, onto the majority if not all GABAergic neurons 
(Fig. 1), and is thus not selective for interneuron type. Expression 
patterns in vivo also suggest selective function of IgSF9b in inter-
neurons, although some levels of expression are also observed in 
cortical and hippocampal CA1 pyramidal cells and cerebellar 
granule cells. Our study did not explore how IgSF9b contributes 
to interneuronal circuitry in the brain. However, in dissociated 
hippocampal cultures, knockdown of postsynaptic IgSF9b in 
GABAergic interneurons suppresses inhibitory synapse number 
and synaptic transmission onto these neurons, whereas the same 
their extracellular domains (Fig. S1 A). Given that their cyto-
plasmic domains are quite dissimilar in amino acid sequences, 
we predict that IgSF9b and Dasm1 have distinct intracellular 
partners mediating different intracellular signaling pathways.
IgSF9b, to the best of our knowledge, represents the fourth 
adhesion molecule that is selectively present at inhibitory syn-
apses, next to neuroligin 2, dystroglycan, and slitrk3 (Lévi et al., 
2002; Varoqueaux et al., 2004; Takahashi et al., 2012).
Of these four proteins, IgSF9b may stand out as a unique 
protein for the following reasons. First, it localizes and functions 
at a distinct subset of inhibitory synapses, which is consistent 
with the known heterogeneity of inhibitory synapses (Lévi et al., 
Figure 8. S-SCAM bridges IgSF9b and neuroligin 2. (A) A schematic diagram showing that IgSF9b and neuroligin 2 bind to two distinct regions of 
S-SCAM (PDZ4-5 and WW-PDZ1, respectively), forming a ternary complex. (B) IgSF9b forms a ternary complex with S-SCAM and neuroligin 2 in HEK293T 
cells, as determined by coimmunoprecipitation analysis. (C) IgSF9b colocalizes with MAGI and neuroligin 2 proteins, but not with PSD-95, in cultured 
hippocampal interneurons (DIV 18–23). NLG2, neuroligin 2. (D) A S-SCAM knockdown construct (sh-S-SCAM), but not a mutant sh-S-SCAM that lacks 
knockdown activity (sh-S-SCAM*), reduces expression of S-SCAM in HEK293T cells. HEK293T cells were doubly transfected with EGFP–S-SCAM + 
sh-S-SCAM, sh-vec (empty shRNA vector), or sh-S-SCAM*, and immunoblotted with the indicated antibodies. EGFP (size corresponds to plain EGFP 
coexpressed from the sh-vectors not the EGFP–S-SCAM fusion) and -tubulin were visualized for normalization. (E) Quantification of the results from D. 
Integrated band intensities of S-SCAM were normalized to that in the control lane (sh-vec). n = 3; *, P < 0.05; ANOVA and Tukey’s multiple comparison 
test. (F and G) Knockdown of S-SCAM reduces colocalization between IgSF9b and neuroligin 2. Cultured hippocampal neurons were transfected with 
sh-S-SCAM, sh-vec, or sh-S-SCAM* (DIV 15–20), and immunostained for the indicated proteins, and interneurons were selected for colocalization analysis. 
n = 19 for sh-vec, 19 for sh-S-SCAM, and 11 for sh-S-SCAM*. *, P < 0.05; **, P < 0.01; ANOVA and Tukey’s multiple comparison test were used. 
(H and I) S-SCAM knockdown reduces the number of VGAT-positive gephyrin clusters in interneurons. Cultured hippocampal neurons were transfected 
with sh-S-SCAM, sh-vec, or sh-S-SCAM* (DIV 15–20), and immunostained for the indicated proteins. n = 18 for sh-vec, 17 for sh-S-SCAM, and 12 for 
sh-S-SCAM*. ***, P < 0.001; ANOVA and Tukey’s multiple comparison test. Error bars indicate mean ± SEM. Bars: (C) 10 µm; (F) 5 µm; (H) 10 µm.
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although additional experiments will be required to explore 
this possibility.
Third, IgSF9b is not sufficient to trigger synapse forma-
tion (Fig. 3), whereas neuroligin 2 and slitrk3 have such activi-
ties. The developmental expression of IgSF9b also lags behind 
that of neuroligin 2 (Fig. 2), and IgSF9b appears at inhibitory 
synapses in hippocampal cultures at a late stage of their devel-
opment (Fig. S2). Therefore, IgSF9b may stabilize the inhibi-
tory synapses initially organized by other adhesion molecules.
Lastly, IgSF9b can be coclustered by presynaptic neurexin 
via neuroligin 2, whereas dystroglycan is not (Graf et al., 2004), 
which suggests that IgSF9b is an inhibitory adhesion molecule 
closely associated with the neurexin–neuroligin system.
Subsynaptic domains at inhibitory 
synapses
Our super-resolution data indicate that IgSF9b and gephyrin/
GABAA receptors (2) distribute to two distinct inhibitory 
knockdown in pyramidal neurons has no effect (Fig. 4 and 
Fig. S4). If IgSF9b has a similar function in vivo, it could be an 
interesting general regulator of inhibitory transmission selec-
tively among GABAergic neurons. Although dystroglycan also 
localizes to a subset of GABAergic synapses (Lévi et al., 2002) 
and neuroligin 2 may contribute functionally to specific subsets 
of GABAergic synapses (Gibson et al., 2009; Poulopoulos et al., 
2009), this selectivity of IgSF9b for GABAergic synapses onto 
GABAergic neurons appears unique.
Second, IgSF9b is distinct in that it is a homophilic cell 
adhesion molecule (Fig. 3), whereas neuroligin 2, dystrogly-
can, and slitrk3 are not. Based on this feature, it is likely that 
the synaptic IgSF9b observed here represents both presynaptic 
and postsynaptic pools. Given that postsynaptic knockdown 
of IgSF9b reduces inhibitory synapse number and function in 
GABAergic interneurons, postsynaptic IgSF9b appears to be 
important. We suspect that IgSF9b may act from the presyn-
aptic side as well, through trans-synaptic homophilic adhesion, 
Figure 9. IgSF9b and neuroligin 2 bidirectionally drive protein clustering. (A) Aggregation of neuroligin 2 by preclustered neurexin 1-Ecto-Fc (NRX1-Fc) 
induces coclustering of IgSF9b only in the presence of S-SCAM in heterologous cells. HEK293T cells expressing combinations of HA-Neuroligin 2 (NLG2), 
EGFP–S-SCAM, and Myc-IgSF9b were incubated with preclustered NRX1-Fc and stained for HA, Myc, EGFP, or Fc. Not all proteins could be visualized 
for the shortage of staining channels. (B and C) Neuroligin 2 aggregation by preclustered NRX1-Fc induces coclustering of endogenous MAGI, IgSF9b, 
and gephyrin at VGAT-negative subcellular sites in neurons. Cultured hippocampal neurons were incubated with NRX1-Fc (DIV 16–17) and immuno-
stained for the indicated proteins. The arrowheads indicate sites of NRX1-Fc clustering. The quantifications represent percent colocalization of the indicated 
proteins (neuroligin 2, MAGI, and IgSF9b) with NRX1-Fc clusters. (D) Direct bead aggregation of IgSF9b induces neuroligin 2 coclustering at synapsin 
I–negative sites in neurons. Cultured hippocampal neurons expressing N-terminally EGFP-tagged IgSF9b, or YFP-tagged CD4 (control; DIV 9–14), were in-
cubated with GFP antibody-coated beads for 24 h and visualized at DIV 15 by double immunofluorescence staining for neuroligin 2 (NLG2) and synapsin I. 
(E) Quantification of the results from D, as measured by mean intensities of neuroligin 2 around beads. n = 81 beads from 24 cells for EGFP-IgSF9b, and 
n = 181 beads from 30 cells for YFP-CD4. ***, P < 0.001; Student’s t test. (F and G) Deletion of neuroligin 2 in mice has minimal effects on overall stabil-
ity or synaptic localization of IgSF9b. Whole brain homogenates (Hom) and synaptic fractions such as synaptosomal membranes (Syn) and PSD fractions 
(PSD I and PSD III) from adult mice brain (4–8 wk) were immunoblotted for IgSF9b. (G) Quantification of the results from F. IgSF9b levels were normalized 
to total protein loading, and then to the mean sample value of all lanes on the same blot to correct for blot-to-blot variance. n = 6 mice for both wild-type 
(WT) and neuroligin 2 knockout (KO). Error bars indicate mean ± SEM. Bars: (A and B) 10 µm; (D, top panels) 10 µm; (D, insets) 2 µm.
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as previously suggested for predetermined postsynaptic hot-
spots for development of functional excitatory synapses (Gerrow 
et al., 2006) and for rapid and efficient assembly of presynaptic 
active zones (Zhai et al., 2001; Shapira et al., 2003).
S-SCAM as an adaptor bridging IgSF9b 
and neuroligin 2
Our data suggest that S-SCAM is important for physical cou-
pling of the two inhibitory subsynaptic domains. In support of 
this notion, S-SCAM forms a ternary complex with IgSF9b and 
neuroligin 2 (Fig. 8). Moreover, S-SCAM knockdown enhances 
mislocalization of IgSF9b and neuroligin 2 (Fig. 8). What would 
be the advantages of S-SCAM as a bridging molecule?
S-SCAM is a protein with multiple domains for protein–
protein interactions (i.e., six PDZ domains) and many known 
binding partners. Therefore, S-SCAM may be able to function 
as a focal site of multiprotein interaction and assembly that 
would support a dynamic and regulated association between 
the two subsynaptic domains. Known S-SCAM–binding proteins 
thus far include neuroligin 1, neuroligin 2, NMDA receptors, 
GKAP/SAPAP, and SynArfGEF (Hirao et al., 1998; Kim and 
Sheng, 2004; Fukaya et al., 2011), where only neuroligin 2 and 
SynArfGEF are inhibitory synaptic proteins. SynArfGEF, a 
guanine nucleotide exchange factor for the Arf6 small GTPases, 
is preferentially localized at inhibitory synapses, and directly 
interacts with dystrophin/utrophin (Fukaya et al., 2011), which, 
together with dystroglycan, are components of the dystrophin-
associated glycoprotein complex. Therefore, S-SCAM has the 
potential to regulate Arf-dependent synaptic membrane/protein 
trafficking at the junction between the two subsynaptic domains, 
and to position the dystrophin-associated glycoprotein complex 
close to this junction.
subsynaptic domains (Fig. 6). This suggests that the two sub-
synaptic domains may have distinct functions. What would be 
the functions?
One possibility is that the IgSF9b-containing domain may 
mediate synaptic adhesion, given that IgSF9b can mediate homo-
philic adhesion, which may act synergistically with the adhesion 
mediated by neurexin and neuroligin 2. Meanwhile, the GABAA 
receptors/gephyrin-containing domain may mediate inhibitory 
synaptic transmission by responding to presynaptic GABA. The 
two subsynaptic domains must be linked functionally, together 
mediating GABAergic synapse development and maintenance, 
as knockdown of IgSF9b in interneurons reduces VGAT-positive 
gephyrin clusters and reduces mIPSC frequency.
Distinct subsynaptic localization of receptors and adhe-
sion molecules have been reported for excitatory synapses, 
where NMDA and AMPA glutamate receptors are present in 
the central region of the synapse (Baude et al., 1993; Chen 
et al., 2008), whereas metabotropic glutamate receptors and 
homophilic adhesion molecules such as N-cadherin are localized 
in the periphery of the synapse (Uchida et al., 1996). However, 
a unique feature of our current finding is that the two subsynap-
tic domains do not display a concentric circular arrangement 
as in excitatory synapses. Rather, the two subsynaptic domains 
have diverse sizes and shapes, and randomly contact with each 
other, forming diverse overall shapes.
Why are there two distinct subsynaptic domains, rather 
than all the synaptic proteins being randomly mixed throughout 
the synapse? It is conceivable that the two functionally distinct 
subsynaptic domains, one for adhesion and the other for trans-
mission, could easily be joined or separated for rapid and effi-
cient formation and elimination of functional synapses. Each 
subsynaptic domain may even represent a preassembled packet, 
Figure 10. Gephyrin can be clustered by neuroligin 2 but not by IgSF9b. (A) Cultured hippocampal neurons expressing N-terminally EGFP/YFP-tagged 
IgSF9b (EGFP-IgSF9b), neuroligin 2 (YFP-NLG2), or CD4 (YFP-CD4; negative control; DIV 19–21), were incubated with GFP antibody–coated beads for 
24 h and visualized at DIV 22 by double immunofluorescence staining for gephyrin and VGAT. Bars: (top) 10 µm; (insets) 2 µm. (B) Quantification of the 
results from A, as measured by mean intensities of gephyrin around beads. Error bars indicate mean ± SEM. n = 150, 104, 109 beads from 22, 21, and 21 
neurons for YFP-CD4, EGFP-IgSF9b, and YFP-NLG2, respectively. ***, P < 0.001; ANOVA and Tukey’s multiple comparison test compared with YFP-CD4. 
(C) Cultured hippocampal neurons expressing EGFP-IgSF9b clustered with GFP antibody–coated beads as above (in A) were immunolabeled for neuroligin 2 
and gephyrin. Bar, 10 µm.
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Materials and methods
DNA constructs
Full-length mouse IgSF9b (accession no. NM_001129787, original GenBank 
version, aa 1–1,441) was amplified by PCR from a mouse brain cDNA 
library (BD) and subcloned into pEGFP-N1 (Takara Bio Inc.) with an intact 
stop codon at the 3 end. Untagged IgSF9b was generated by subcloning 
of full-length IgSF9b (aa 1–1,441) into pGW1 (British Biotech). Myc epitope 
(EQKLISEEDL) and EGFP was inserted between residues 28 and 29 of 
IgSF9b in pGW1 and pEGFP-N1, respectively. Ecto-domains of IgSF9b 
(aa 1–716) were subcloned into pEGFP-N1 in which EGFP was replaced 
with human Fc and pDisplay (Invitrogen). The C-terminally Flag-tagged IgSF9b 
that lacks a cytosolic region (aa 1–756) was subcloned into pEGFP-N1, 
which has triple Flag motifs with a stop codon. For the yeast two-hybrid 
assay, the last 75 aa of IgSF9b were subcloned into pBHA (bait vector). 
For siRNA knockdown, nucleotides 216–234 (5-CATCAAGTTTGGCTAC-
TAT-3) of rat IgSF9b, its point mutant (5-CATAAAGTTCGGCTACTAT-3), 
nucleotides 1,328–1,346 (5-GAGATGAGCCGGACGAGTT-3) of rat 
S-SCAM, and its point mutant (5-GAGACGAGCCTGATGAGTT-3) were 
selected and subcloned into pSuper.gfp/neo (OligoEngine). For N-terminally 
EGFP tagged S-SCAM, full-length rat S-SCAM (GenBank accession no. 
NM_053621, aa 1–1,277) was amplified from untagged S-SCAM and 
subcloned into pEGFP-C1 (Takara Bio Inc.). The following deletion variants 
of S-SCAM were also subcloned into pEGFP-C1: PDZ0-GK (aa 1–301), 
WW-PDZ1 (aa 296–578), PDZ2-5 (aa 573–1,277), PDZ1-2 (aa 417–710), 
PDZ2-3 (aa 573–892), PDZ3-4 (aa 747–1,028), and PDZ4-5 (aa 867–
1,277). For N-terminally EGFP-tagged MAGI-1, full-length rat MAGI-1 
(NM_001030045, aa 1–1,255) was amplified from a rat brain cDNA 
library (BD) and subcloned into pEGFP-C1. The following expression con-
structs have been described previously: YFP-gephyrin (rat gephyrin isoform 
2.6 was subcloned into modified pLentiLox3.7; Dobie and Craig, 2011), 
HA-NLG2 (a gift from P. Scheiffele, Biozentrum of the University of Basel, 
Basel, Switzerland; mouse neuroligin-2 was subcloned into pNICE; Scheiffele 
et al., 2000), YFP-CD4 (a mature form of CD4 was subcloned into spYFP-C1; 
Takahashi et al., 2011), YFP-NLG2 (modified from HA-NLG2; Graf et al., 
2004), untagged S-SCAM (from Y. Hata, Graduate School of Medi-
cine, Tokyo Medical and Dental University, Tokyo, Japan; full-length rat 
S-SCAM was subcloned into pCMV5; Hirao et al., 1998), and NRX1-Fc 
(pCMVIgbN1-1 from T.C. Sudhof, Stanford University Medical School, 
Stanford, CA; aa 1–300 of rat neurexin-1 lacking an insert in splice site #4 
was subcloned into pCMV-Ig; Ko et al., 2009).
Antibodies
Guinea pig (1593) and rabbit (1913) polyclonal IgSF9b antibodies were 
raised against GST-IgSF9b aa 1,126–1,351 (226 aa) and aa 1,293–
1,441 (149 aa), respectively. GST–S-SCAM aa 303–405 (103 aa, WW 
domains) was used as an immunogen to generate guinea pig (2015) and 
rabbit (2013) polyclonal S-SCAM antibodies. The following antibodies 
have been described previously: EGFP (1432, guinea pig, H6-EGFP aa 
1–240; Choi et al., 2006), PSD-95 (SM55, rabbit, H6-PSD-95 aa 77–
299; Choi et al., 2002), neuroligin 2 (rabbit, RGGGVGADPAEALRPACP; 
Varoqueaux et al., 2004; Graf et al., 2006), S-SCAM (1146, rabbit, H6-
S-SCAM aa 341–711; Mok et al., 2002), S-SCAM (42574, rabbit, GST–
S-SCAM aa 303–405, a gift from Y. Hata), PSD-93 (1634, rabbit, 
GST–PSD-93, full-length; Kim et al., 2009), Shank (1123, guinea pig, GST-
Shank1 aa 469–691; Lim et al., 2001), and GluR1 (1193, rabbit, SHSSGM-
PLGATGL; Kim et al., 2009). The following antibodies are commercially 
available: GABAAR2, vGlut1, VGAT, gephyrin, neuroligin 2 (Synaptic 
Systems); neuroligin1, Myc, and HA (Santa Cruz Biotechnology, Inc.); 
IgSF9b (HPA010802; rabbit), MAP2, -tubulin, Flag, and synaptophysin 
(Sigma-Aldrich); PSD-95 (Thermo Fisher Scientific); GABAAR1 (Alomone 
Labs); GAD67, synapsin I (EMD Millipore), and GAD65 (Developmental Stud-
ies Hybridoma Bank); GAD65/67 (Enzo Life Sciences); and Cy3-conjugated 
anti-Fc (Jackson ImmunoResearch Laboratories, Inc.).
Deglycosylation assay
Enzymatic deglycosylation was performed with rat P2 (crude synapto-
somes) fractions extracted with 1% deoxycholate (DOC) using N-glycosidase/
PNGase F (New England Biolabs, Inc.), sialidase/neuraminidase (Roche), 
and O-glycosidase/endo--N-acetylgalactosaminidase (EMD Millipore) 
according to the manufacturer’s instructions.
In situ hybridization analysis
In situ hybridization was performed as described previously (Kim et al., 
2003). In brief, adult rats and mice brains (6 wk) were rapidly extracted 
This concept of a multidomain connector for neighboring 
macromolecular structures is reminiscent of the finding that 
dynamin-3, a GTPase with multiple domains for protein–protein 
interactions, positions the endocytic zone, an excitatory postsyn-
aptic hotspot for local AMPA receptor endocytosis (Blanpied 
et al., 2002), close to the PSD via its direct interaction with 
Homer, a PDZ and EVH1 domain–containing adaptor protein in 
the PSD (Lu et al., 2007).
Bidirectional protein clustering by IgSF9b 
and neuroligin 2
As in excitatory synapses, molecular organization of inhibitory 
postsynaptic protein complexes involves key synaptic scaffolding 
proteins such as gephyrin (Fritschy et al., 2008, 2012; Tyagarajan 
and Fritschy, 2010; Sheng and Kim, 2011). Gephyrin forms 
homomultimers and interacts with diverse postsynaptic mem-
brane, signaling, and cytoskeletal proteins. This gephyrin-based 
postsynaptic protein assembly is thought to be initiated by the 
clustering of neuroligin 2 driven by presynaptic neurexins (Craig 
and Kang, 2007; Südhof, 2008; Shen and Scheiffele, 2010; 
Krueger et al., 2012). Our results extend this view of inhibitory 
postsynaptic assembly. Specifically, initial clustering of neuroli-
gin 2 appears to induce coclustering of S-SCAM and IgSF9b, in 
addition to gephyrin, in order to strengthen synaptic adhesion.
Therefore, functions of neuroligin 2 as a postsynaptic or-
ganizer at inhibitory synapses appear to be multifold. They are 
to induce clustering of (1) gephyrin and associated proteins for 
postsynaptic differentiation, (2) S-SCAM and IgSF9b for lateral 
association with a subsynaptic adhesive domain, and (3) pre-
synaptic neurexins for presynaptic differentiation.
Our data suggest that IgSF9b and neuroligin 2 can recip-
rocally cluster each other (Fig. 9). Possible functions of neuro-
ligin 2 clustering by IgSF9b are unclear. Postsynaptic assembly 
in this direction may have a limited impact given the findings 
from the artificial aggregation assays that IgSF9b drives protein 
clustering up to neuroligin 2 but not beyond to gephyrin, whereas 
neuroligin 2 can cluster gephyrin in addition to IgSF9b. How-
ever, the bidirectional clustering between IgSF9b and neuroli-
gin 2 may enhance the chance or rate of forming the connection 
between the two subsynaptic domains. Altogether, the recipro-
cal clustering of IgSF9b and neuroligin 2 is likely to enhance 
the development and stabilization of inhibitory synapses, par-
ticularly in interneurons where IgSF9b is abundant.
In conclusion, our data identifies a novel inhibitory synap-
tic adhesion molecule IgSF9b that localizes to a distinct sub-
synaptic domain and is coupled to neuroligin 2 via S-SCAM to 
promote inhibitory synaptic development. A direction for future 
studies would be to explore the functional significance of the 
two subsynaptic domains, and related regulatory mechanisms. 
The selective localization and function of IgSF9b at inhibitory 
synapses onto GABAergic interneurons, at least in culture, place 
IgSF9b in a unique position among inhibitory synaptic adhe-
sion proteins and identify it as a potential drug target. Para-
doxically, we predict that down-regulation of IgSF9b level or 
function, through selectively reducing inhibition onto GABAergic 
neurons, may increase GABAergic transmission to pyramidal 
cells and reduce overall circuit excitation
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Inhibitory interneurons were distinguished from excitatory pyramidal 
neurons by immunostaining with GABAergic neuronal markers such as 
GAD67 and/or by morphological aspects such as polygonal shaped cell 
bodies, less spiny and nontapered dendrites with longer segments between 
branch points (Benson et al., 1994). To determine the density of synaptic 
protein clusters, every primary dendritic segment encompassing 50 µm 
from cell bodies of each neuron was analyzed. For quantitation of images 
from coculture assays, all captured images were thresholded and the 
integrated intensity of the clusters on transfected HEK293T cells was nor-
malized to the cell area. All values are presented as mean ± SEM and 
analyzed by Student’s t test or one-way analysis of variance (ANOVA) with 
Tukey’s multiple comparison test.
For STORM analysis, neurons were rinsed and fixed with 3% formal-
dehyde and 0.1% glutaraldehyde, and primary antibodies (2.5 µg/ml 
anti-gephyrin, 2 µg/ml rabbit anti-IgSF9b, and 2.5 µg/ml guinea pig anti–
GABAAR 2). Secondary antibodies (Jackson ImmunoResearch Laboratories, 
Inc.) were labeled with a mixture of amine-reactive activators and reporters. 
Alexa Fluor 405 (Invitrogen) and Cy3 (GE Healthcare) were used as the 
activators, and Alexa Fluor 647 (Invitrogen) was used as the reporter. Con-
centrations of reactive dyes were controlled such that each antibody had, on 
average, two activator molecules and 0.6–0.8 reporter molecules.
Imaging was done as described previously (Huang et al., 2008). In 
brief, STORM images were captured by a super-resolution microscope 
(N-STORM; Nikon) using a 100×, 1.4 NA objective lens and an EM 
charge-coupled device camera (iXon3 897; Andor Technology) at room 
temperature in a standard imaging buffer that contains 50 mM Tris, pH 
7.5, 10 mM NaCl, 0.5 mg/ml glucose oxidase, 40 µg/ml catalase, 10% 
(wt/vol) glucose, and 0.1 M mercaptoethylamine. Two activation lasers 
and one imaging laser are individually shuttered and illuminate the sample 
in total internal reflection fluorescence mode. An objective positioner 
(Nano F-100; Mad City Labs Inc.) was used to stabilize the focusing of the 
microscope. For two-color imaging, a similar repetitive sequence of activa-
tion imaging (1 frame of activation followed by 3 frames of imaging) was 
used with two activation lasers. 405-nm light from the CUBE laser (Coherent) 
was used to activate the A405-A647 pair, and 561-nm light from a solid 
state laser (SAPPHIRE; Coherent) was used to activate the Cy3-A647 pair. 
A 647-nm laser from the CrystaLaser (DL647-100) was used for imaging. 
The localizations were later color-coded based on whether the A647 emis-
sion was detected after the 405-nm or 561-nm activation light. Typical laser 
powers used for STORM imaging were 60 mW for the imaging laser and 
2 µW–5 µW for each of the activation lasers. A typical STORM image 
cycle was repeated 15,000–20,000 times until eventually fluorescence 
bleached. We used NIS-Elements software (Nikon) for correction of image 
drift and cross-talk statistically. For two-color STORM images, each local-
ization was assigned as one point in the STORM image and was false-colored 
according to the color of the activation laser pulse.
Electrophysiology
Cultured hippocampal neurons were transfected with sh-IgSF9b (DIV 15–20), 
and interneuron-shaped cells, as defined by morphology (Benson et al., 
1994), were whole-cell voltage-clamped at 60 mV using an Axopatch 
200B amplifier (Molecular Devices). To ensure that morphologically identi-
fied cells were GABAergic interneurons, we marked cells with biocytin infu-
sion followed by GAD67 staining, and found that 93% of the cells were 
GAD67-positive (n = 15). The extracellular solution contained (in mM): 
145 NaCl, 2.5 KCl, 10 Hepes, 1.25 NaH2PO4, 2 CaCl2, 1 MgCl2, 10 
glucose, and 0.4 sodium ascorbate. For mIPSC, the intracellular solution 
contained (in mM): 135 KCl, 10 Hepes, 8 NaCl, 4 Mg-ATP, 0.3 Na-GTP, 
and 0.5 EGTA. For mEPSC, the intracellular solution contained (in mM): 100 
K-gluconate, 20 KCl, 10 Hepes, 8 NaCl, 4 Mg-ATP, 0.3 Na-GTP, and 0.5 
EGTA. During measurement, 1 µM TTX, 50 µM AP5, and 10 µM NBQX (all 
from Tocris Bioscience) for mIPSC or TTX and bicuculline (10 µM; Tocris) for 
mEPSC were added into the extracellular solution. Synaptic currents were 
analyzed using a custom-written macro in Igor Pro (WaveMetrics).
Online supplemental material
Fig. S1 shows amino acid sequence alignment of IgSF9b and Dasm1/
IgSF9, and generation and characterization of IgSF9b antibodies. Fig. S2 
shows distribution of IgSF9b mRNAs revealed by three independent in situ 
hybridization probes, and gradually increasing levels of IgSF9b proteins 
in cultured hippocampal neurons. Fig. S3 shows that IgSF9b-expressing 
HEK293T cells induce clustering of IgSF9b in contacting neurites of co-
cultured GAD67-positive interneurons and GAD67-negative pyramidal 
neurons, but do not induce clustering of VGAT or vGlut1 in contacting 
axons or dendritic clustering of gephyrin in interneurons or in pyramidal 
neurons. Fig. S4 shows characterization of IgSF9b knockdown constructs, 
and frozen in isopentane. Brain sections (12 µm thick) were prepared with 
a cryostat (CM 3000; Leica) and then thaw-mounted on gelatin-coated glass 
slides. Sections were fixed in 4% paraformaldehyde, washed with PBS, 
acetylated with 0.25% acetic anhydrides in 0.1 M triethanolamine/0.9% 
NaCl, pH 8.0, dehydrated in ethanol and chloroform, and then air-dried. 
A rat IgSF9b antisense riboprobe corresponding to nt 3,532–4,164 
(633 bp) was generated by RNA polymerase transcription using a Ribo-
probe System (Promega) in the presence of -[35S]-UTP. The sections were 
hybridized with 35S-labeled probes at 52°C overnight, and then washed 
four times in 4× SSC solution at room temperature. Subsequently, the 
slides were incubated with RNase buffer at 37°C for 30 min and washed. 
Slides were dehydrated, air-dried, exposed, and developed in a developer 
(D-19; Kodak). For in situ hybridization using mouse brain sections, we used 
the following mouse IgSF9b antisense riboprobes: nt 325–960 (636 bp) 
for probe “a,” nt 3,428–3,999 (572 bp) for probe “b” (with the last 
4 nt corresponding to mRNA of IgSF9b-2), and nt 3,995–4,326 (332 bp) 
for probe “c.”
Brain fractionation and coimmunoprecipitation
Subcellular and PSD fractions of adult rat and mouse brains were prepared 
as described previously (Carlin et al., 1980; Huttner et al., 1983). In brief, 
rat brain homogenates (H) were centrifuged at 1,000 g to remove nuclei 
and other large debris (P1). The supernatant was centrifuged at 10,000 g 
to obtain a crude synaptosome fraction (P2), and the supernatant (S2) was 
further centrifuged at 160,000 g to obtain light membranes (P3) and 
cytosol fractions (S3). In parallel, the P2 fraction was subjected to hypotonic 
lysis and centrifuged at 25,000 g to precipitate synaptosomal membranes 
(LP1). The supernatant (LS1) was further centrifuged at 160,000 g to 
obtain a crude synaptic vesicle-enriched fraction (LP2) and soluble fraction 
(LS2). To obtain PSD fractions, the synaptosomal fraction was extracted 
with detergents, once with Triton X-100 (PSD I), twice with Triton X-100 
(PSD II), and once with Triton X-100 and once with Sarkosyl (PSD III). 
Protein loading was quantified using the Pierce Reversible Protein Stain 
kit (Thermo Fisher Scientific). For in vivo coimmunoprecipitation, the P2 
fraction of adult rat brain was extracted in buffer containing 1% sodium 
deoxycholate and 50 mM Tris-HCl, pH 9.0, followed by incubation with 
immunoprecipitation antibodies. For coimmunoprecipitation in heterolo-
gous cells, cells were extracted in phosphate buffered saline containing 
1% Triton X-100.
Coculture assay
Coculture assays were performed as described previously (Kim et al., 2006; 
Biederer and Scheiffele, 2007). In brief, primary hippocampal neuron cul-
tures at DIV 10 prepared from embryonic day 18–19 rats were cocultured 
with HEK293T cells expressing pDisplay-IgSF9b or EGFP. The cocultured 
cells were immunostained with synapsin1, PSD-95, or gephyrin antibodies.
Neuron culture, transfection, and immunocytochemistry
Primary hippocampal neuronal cultures were prepared from embryonic 
day 18–19 rat hippocampi as described previously (Goslin and Banker, 
1991). Cultures were plated on coverslips coated with poly-l-lysine and 
laminin, and grown in neurobasal medium supplemented with B27 (Invit-
rogen) and 2% fetal bovine serum (Gibco) in a 10% CO2 incubator. Cul-
tured neurons were transfected using a calcium phosphate transfection kit 
(Takara Bio Inc. and Promega) and fixed with 4% paraformaldehyde/4% 
sucrose, permeabilized with 0.2% Triton X-100 in PBS, and incubated 
with the specific primary antibodies. Secondary antibodies were conju-
gated with Cy3, Cy5, or FITC (Jackson ImmunoResearch Laboratories, 
Inc.) or with Alexa Fluor 488, Alexa Fluor 568, or Alexa Fluor 647 (Invi-
trogen). For the application of preclustered neurexin1 ectodomain 
(NRX1-Fc) to cultured neurons, preclustered NRX1-Fc was generated 
by preincubation of Cy3-conjugated anti-Fc antibody with NRX1-Fc in 
neuronal culture medium and incubated with hippocampal cultures for 
24 h (DIV 16–17). For the bead clustering assay, nonfluorescent Neutra-
vidin FluoSpheres (F-8777; Invitrogen) were rinsed in PBS containing 
100 µg/ml BSA (PBS/BSA) and incubated with biotin-conjugated 
anti-GFP (which can also recognize YFP; Rockland Immunochemicals) at 
6 µg antibody/µl beads in PBS/BSA at RT for 2 h. Beads were applied 
to hippocampal neuron cultures for 24 h.
Image acquisition and quantification
Fluorescent images were randomly acquired as z stacks using a confocal 
microscope (LSM510; Carl Zeiss) or on an epifluorescence microscope 
(Axioplan; Carl Zeiss) using C-Apochromat 63×, 1.20 NA water-immersion 
or 63×, 1.40 NA oil-immersion objective lenses at room temperature and 
analyzed with MetaMorph image analysis software (Universal Imaging). 
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